W. Han

发表

A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly

J. Xia, Q. Ye, Jing Li, 2018, Human vaccines & immunotherapeutics.

Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in China

K. Chu, Changgui Li, K. Xu, 2019, Open forum infectious diseases.

Cross-neutralization Capacity of Immune Serum from Different Dosage of Sabin Inactivated Poliovirus Vaccine Immunization against Multiple Individual Polioviruses

K. Chu, Wenbo Xu, Yuemei Hu, 2021, Expert review of vaccines.

Safety, Immunogenicity and Lot-to-Lot Consistency of Sabin-Strain Inactivated Poliovirus Vaccine in 2-Month-Old Infants: A Double-Blind, Randomized Phase III Trial

Changgui Li, Jian-feng Wang, Z. Ying, 2022, Vaccines.

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

K. Chu, Xiangxi Wang, Changgui Li, 2020, The Lancet Infectious Diseases.

Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: A further observation

K. Chu, F. Zhu, Jing Zhang, 2018, Human vaccines & immunotherapeutics.

Diagnostic accuracy of three prevailing rapid antigen tests for detection of SARS-CoV-2 infection in the general population: cross sectional study

J. H. van de Wijgert, K. Moons, Z. Iglói, 2021, medRxiv.

Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial

K. Chu, Xiangxi Wang, B. Kan, 2020, medRxiv.